05:46 PM EDT, 07/17/2024 (MT Newswires) -- Jeff E. Knight, Chief Operating Officer, on July 15, 2024, sold 27,000 shares in Crinetics Pharmaceuticals ( CRNX ) for $1,485,000. Following the Form 4 filing with the SEC, Knight has control over a total of 51,653 shares of the company, with 51,653 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000095017024084346/xslF345X03/ownership.xml